Moores Members Receive Research Heroes Award
|
The Prebys Foundation, in partnership with the Science Philanthropy Alliance, awarded $500,000 research grants to 14 women scientists in San Diego who are transforming treatments for cancer and other illnesses. Moores Members Stephanie Fraley, PhD, Marygorret Obonyo, PhD, Erica Saphire, PhD, and Sonia Sharma, MD, PhD were among the recipients of these grants. Congratulations. Learn More >>
|
Moores Member to Receive UC San Diego Health Sciences Faculty Excellence in Mentoring Award
|
Moores Member Lyudmila Bazhenova, MD will receive the Faculty Excellence in Mentoring Award at the 2024 Annual Mentoring Excellence Celebration. Kudos to Dr. Bazhenova. Learn More and Register >>
|
|
|
Moores to Co-host Delivering Discoveries: Updates in Oncology CME
|
Faculty from UC San Diego and SDSU, among others, will present the latest cancer research to improve patient outcomes, spanning all aspects of cancer, from basic science and clinical advances to community-based prevention and interception strategies.
The $20 code for those working at FQHC is FQHC20.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
LOI Deadline: November 2, 2024
Application Deadline: December 2, 2024
Budget | Period: $500,000 | 5 years
|
|
|
The Researcher Spotlight is designed to help you connect with fellow researchers, gain insights into their diverse projects, and discover the paths that led them to their current roles. Uncover a personal touch to their professional achievements, showcasing the varied perspectives within our cancer research community.
|
J. Silvio Gutkind, PhD, is a basic scientist with a passion for exploiting the emerging information on dysregulated signaling circuitries and individual genomic and molecular alterations to identify new therapeutic options to prevent and treat cancer. His lab's basic studies and translational efforts have already made an impact in the development of individualized, mechanism-based molecular-targeted (precision) anticancer treatments and immunotherapeutic strategies.
|
|
|
| Transforming cancer research through informatics
|
Jill P. Mesirov, PhD (Structural and Functional Genomics)
|
|
|
| Defining precancer: A grand challenge for the cancer community
|
Scott M. Lippman, MD (Cancer Control Program)
|
|
|
|
The epigenetic state of the cell of origin defines mechanisms of leukemogenesis
|
Dennis J. Kuo, MD, MS (Hematologic Malignancies)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
CLINICAL TRIALS
D7984C00002: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre, Global Study of Volrustomig in Women with High Risk Locally Advanced Cervical Cancer Who Have Not Progressed Following Platinum-Based, Concurrent Chemoradiation Therapy (eVOLVE-Cervical)
PI: Jyoti Mayadev, MD
NCT: NCT06079671
|
|
|
|
